TalkMed Group Limited (SGX:5G3)

TalkMed Group Income Statement

Financials in millions SGD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	78.18	83.79	76.6	60.75	62.14
Other Revenue	-	-	-	-	0.18
Revenue	78.18	83.79	76.6	60.75	62.31
Revenue Growth (YoY)	-6.70%	9.39%	26.10%	-2.52%	-17.96%
Cost of Revenue	33.46	33.78	29.44	26.04	24.38
Gross Profit	44.72	50.01	47.16	34.7	37.94
Selling, General & Admin	0.06	0.07	0.06	0.05	0.05
Other Operating Expenses	8.89	7.79	5.16	4.86	5.16
Operating Expenses	12.65	11.19	8.26	7.91	10.83
Operating Income	32.07	38.83	38.9	26.8	27.11
Interest Expense	-0.2	-0.21	-0.21	-0.22	-0.24
Interest & Investment Income	2.55	2.61	0.88	0.33	0.71
Earnings From Equity Investments	11.69	-1.51	-2.26	-1.08	-1.09
Other Non Operating Income (Expenses)	3.32	0.03	0.15	0.11	-0.09
EBT Excluding Unusual Items	49.44	39.75	37.47	25.95	26.4
Gain (Loss) on Sale of Investments	-	-0.65	-0.44	-	-
Gain (Loss) on Sale of Assets	-	-	-	1	-
Asset Writedown	-	-0.99	-	-	-3.41
Other Unusual Items	-	-0.29	-0.18	0.34	1.81
Pretax Income	49.44	37.82	36.85	27.29	24.81
Income Tax Expense	7.04	8.46	7.86	5.86	6.29
Earnings From Continuing Operations	42.4	29.35	28.99	21.43	18.52
Minority Interest in Earnings	1.4	2.82	1.56	3.69	4.25
Net Income	43.79	32.18	30.55	25.12	22.77
Net Income to Common	43.79	32.18	30.55	25.12	22.77
Net Income Growth	36.10%	5.33%	21.63%	10.30%	-36.31%
Shares Outstanding (Basic)	1,327	1,324	1,322	1,320	1,317
Shares Outstanding (Diluted)	1,339	1,332	1,329	1,327	1,324
Shares Change (YoY)	0.51%	0.18%	0.19%	0.21%	0.73%
EPS (Basic)	0.03	0.02	0.02	0.02	0.02
EPS (Diluted)	0.03	0.02	0.02	0.02	0.02
EPS Growth	35.12%	5.22%	21.69%	9.88%	-36.76%
Free Cash Flow	28.41	41.02	36.98	22.39	29.32
Free Cash Flow Per Share	0.02	0.03	0.03	0.02	0.02
Dividend Per Share	0.009	0.022	0.030	0.016	0.013
Dividend Growth	-59.09%	-26.67%	87.50%	18.52%	-41.30%
Gross Margin	57.20%	59.69%	61.57%	57.13%	60.88%
Operating Margin	41.02%	46.34%	50.79%	44.11%	43.50%
Profit Margin	56.02%	38.40%	39.88%	41.34%	36.54%
Free Cash Flow Margin	36.34%	48.96%	48.27%	36.85%	47.05%
EBITDA	33.1	39.49	39.42	27.19	28.53
EBITDA Margin	42.34%	47.13%	51.46%	44.76%	45.78%
D&A For EBITDA	1.04	0.66	0.52	0.39	1.42
EBIT	32.07	38.83	38.9	26.8	27.11
EBIT Margin	41.02%	46.34%	50.79%	44.11%	43.50%
Effective Tax Rate	14.24%	22.38%	21.32%	21.47%	25.36%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.